On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Coriell Institute For Medical Research

InstitutionResearch output, impact & collaborations

Coriell Institute For Medical Research is a institution indexed in ScholarIQ from OpenAlex.

What is known about Coriell Institute For Medical Research?

ScholarIQrecord summary

Coriell Institute For Medical Research is a research organisation in Camden, US. OpenAlex records 952 works and 450,402 citations for it. 234 researchers list it as their most recent affiliation.

How many works does Coriell Institute For Medical Research have?

ScholarIQindexed works

Coriell Institute For Medical Research has 952 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Coriell Institute For Medical Research →

How many citations does Coriell Institute For Medical Research have?

ScholarIQcitation count

Coriell Institute For Medical Research has 450,402 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Coriell Institute For Medical Research →

How many researchers are at Coriell Institute For Medical Research?

ScholarIQresearcher count

Coriell Institute For Medical Research has 234 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Coriell Institute For Medical Research?

ScholarIQavg h-index

Coriell Institute For Medical Research has an average h-index of 59.7 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Coriell Institute For Medical Research?

ScholarIQror

The ROR for Coriell Institute For Medical Research is on the source record.

Open the ROR →

What is the OpenAlex record for Coriell Institute For Medical Research?

ScholarIQopenalex

The OpenAlex for Coriell Institute For Medical Research is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Coriell Institute For Medical Research?

ScholarIQtop researchers by citations

Neda Gharani · Ovarian function and disorders

53 works61,905 citations

Jean‐Pierre J. Issa · Epigenetics and DNA Methylation

967 works61,451 citations

Alissa Resch · Genomics and Phylogenetic Studies

26 works42,452 citations

What are the most-cited papers on Coriell Institute For Medical Research?

ScholarIQmost cited works

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

James G. Herman, Adrian Merlo, Li Mao, Rena G. Lapidus, Jean‐Pierre J. Issa, Nancy E. Davidson, David Sidransky, Stephen B. Baylin

PubMed. 19951,359 Citations

Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer

Scott Kopetz, Jayesh Desai, Emily Chan, J. Randolph Hecht, Peter J. O’Dwyer, Dipen M. Maru, Van K. Morris, Filip Jankú, Arvind Dasari, Woonbok Chung, Jean‐Pierre J. Issa, Peter Gibbs, Brian P. James, Garth Powis, K. B. Nolop, Suman Bhattacharya, Leonard B. Saltz

Journal of Clinical Oncology. 2015697 CitationsOPEN ACCESS

Aging and DNA methylation in colorectal mucosa and cancer.

Nita Ahuja, Qing Li, Avinash Mohan, Stephen B. Baylin, Jean‐Pierre J. Issa

PubMed. 1998623 Citations

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.

Manel Esteller, M Toyota, Montse Sánchez‐Céspedes, Gabriel Capellá, Miguel A. Peinado, D. Neil Watkins, Jean‐Pierre J. Issa, David Sidransky, S B Baylin, James G. Herman

PubMed. 2000543 Citations

DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia

Allen S. Yang, Ketan D. Doshi, Sang‐Woon Choi, Joel B. Mason, Rajan K. Mannari, Vazganush Gharybian, Rene Luna, Asif Rashid, Lanlan Shen, Marcos R. Estecio, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Jean‐Pierre J. Issa

Cancer Research. 2006268 Citations

How much of the research on Coriell Institute For Medical Research is open access?

ScholarIQopen access share

17%OPEN ACCESS

Gold

Green

Hybrid

17%

Bronze

Closed

83%